Eltrombopag (Revolade®)

DRUG2 trials

Sponsors

University Children's Hospital Basel, Melbourne Health

Conditions

Aplastic Anemia IdiopathicPoor Graft FunctionPrimary Immune Thrombocytopenia (ITP)

Phase 1

REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2

Not yet recruitingNCT06607367

Melbourne HealthAplastic Anemia Idiopathic, Poor Graft Function

Start: 2024-10-30End: 2026-10-30Target: 20Updated: 2024-09-23

Phase 2

Immunomodulation With Eltrombopag in ITP

CompletedNCT04812483

University Children's Hospital BaselPrimary Immune Thrombocytopenia (ITP)

Start: 2022-09-01End: 2024-04-11Updated: 2024-10-15